ACAygul Celtik

Aygul Celtik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aygul Celtik has a total of 156 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Distribution of Human Leukocyte Antigen Antibodies Among Renal Transplant Recipients: Single-Center Experience

    by Servet Uluer Biçeroğlu, Aygül Çeltik, Zeynep Deveci, Salime Seda Altan, Gülay Aşçı, Ayhan Dönmez

    Objective: Single antigen bead (SAB) tests on Luminex platform are widely used for donor-specific antibody (DSA) detection. This study aimed to evaluate the frequency of anti-HLA antibody profiles based on SAB test results. Materials and Methods: A total of 317 SAB tests that were performed between January 2022 and September 2025 were included in the retrospective analysis. For patients under follow-up, only the most recent results were evaluated. Antibodies against HLA-A, HLA-B, HLA-DRB1, and HLA-DQB1 with a mean fluorescence intensity (MFI) ≥10,000 were analyzed. Results: Among 145 SAB-positive patients with MFI ≥10,000, 63 (43.4%) were positive for Class I, 42 (29%) for Class II, and 40 (27.6%) for both Class I and Class II antibodies. A total of 1,440 Class I antibodies were detected (anti-HLA-A: 541, anti-HLA-B: 899). For Class II, a total of 740 antibodies were identified (anti-DQB1: 524 [78.8%], anti-DRB1: 216 [29.1%]). The most frequent antibodies were as follows: HLA-A: A2 (12.2%), A68 (9.2%), A24 (8.9); HLA-B: B57 (6.2%), B51 (5.0%), B27 (4.8); HLA-DRB1: DR4 (27.3%), DR9 (14.3%), DR15 (7.9); HLA-DQB1: DQ6 (25.6%), DQ7 (17.2%), DQ4 (16.9). Conclusion: The distribution of detected antibodies was consistent with HLA allele frequencies reported in the Turkish population. Among Class II antibodies, the high prevalence of anti-DQB1 antibodies was particularly noteworthy. Accumulating evidence in the literature suggests that DQB1 antibodies may play a significant role in graft rejection. These findings indicate that the HLA-DQB1 locus should be included in pre-transplant compatibility assessment, especially for re-transplant candidates. Keywords: Single antigen bead assay, HLA antibody, donor specific antibody

  • Is Serum Magnesium Level Associated With Serum Lipid Levels in Kidney Transplant Recipients?

    by Berk Goktepe, Aygul Celtik, Goktug Kivratma, Taylan Ozgur Sezer, Gulay Asci, Huseyin Toz


  • The change of mean platelet volume and mean platelet volume to platelet count ratio one year after iniation of peritoneal dialysis

    by Aygul Celti̇k, Zalal Alatas, Mumtaz Yi̇lMaz, Meltem Sezi̇s-Demi̇rCi̇, Gulay Asci̇, Mehmet Ozkahya, Ercan Ok

    Aim: Cardiovascular diseases are the most common cause of mortality in patients undergoing peritoneal dialysis. Thrombocyte indices which are indicators of platelet activation are predictors of cardiovascular events. We aim to examine the change in platelet count, mean platelet volume, and mean platelet volume to platelet count ratio one year after initiation of peritoneal dialysis in patients with end-stage renal disease. Materials and Methods: This retrospective study included 28 patients. Demographic and clinical characteristics of the patients at the time of initiation of peritoneal dialysis were recorded from the patient files. Laboratory data within the last month before the initiation of peritoneal dialysis and in the first year were recorded from the patient files. The mean platelet volume to platelet count ratio was calculated as mean platelet volume (femtolitres) divided by platelet count (number of thousand platelets/microliter). Results: The mean age was 51.1 ± 14.6 years, and 42.8% of the patients were male. Diabetic nephropathy and hypertensive nephropathy were the most common causes of end-stage renal disease. One year after the initiation of peritoneal dialysis, the urea level decreased significantly, and C-reactive protein level increased significantly. Platelet count increased from 240 ± 55 x10 3 /μL to 274 ± 53 x10 3 /μL (p=0.003) and mean platelet volume decreased from 10.7 ± 1.0 fl to 10.2 ± 0.8 fl (p

  • Is Loss of Residual Renal Function Related to Longitudinal Uric Acid and CRP Levels in Peritoneal Dialysis Patients?

    by Aygül Çelti̇k, Zalal Alataş, Mümtaz Yilmaz, Meltem Sezi̇ş Demi̇rCi̇, Gülay Aşçi, Hüseyin Töz, Mehmet Özkahya


  • Open Access

    A Histopathological Scoring and Grading System for Renal Non-aa Amyloidosis: Prediction of Clinical Manifestations and Outcomes 

    by Aygul Celtik, Sait Sen, Fatma Keklik Karadag, Guray Saydam, Gulay Asci, Banu Sarsik, Mehmet Ozkahya, Huseyin Toz

    Background: Kidney involvement is a common manifestation that contributes to morbidity and mortality in systemic amyloidosis. Amyloid load can be predicted by histopathological grading of amyloid deposits in kidney biopsy specimens. Our aim was to determine the relationship of renal amyloid deposition grade with clinical manifestations and outcomes in patients with biopsy proven renal non-AA amyloidosis. Methods: This retrospective cohort study included 74 subjects with renal non-AA amyloidosis (52 AL amyloidosis and 22 unclassified amyloidosis). Baseline characteristics and follow-up data were recorded. Pattern and quantity of amyloid deposition in glomeruli, interstitium, vessels and tubulointerstitial changes were scored. Renal Amyloid Prognostic Score (RAPS) was obtained by addition of all scores and divided into three grades (RAPS grade I, II, III). Results: In AL amyloidosis group, median follow-up was 11 (4-45 months). Among 52 patients, 17 received autologous stem cell transplantation and 29 received bortezomib based chemotherapy. Baseline eGFR was significantly lower among patients with RAPS grade III. Renal survival was significantly lower among patients with RAPS grade III. Patient survival was not significantly different according to RAPS grade. Type of amyloid could not be determined in 22 patients. In this group, baseline eGFR was significantly lower in patients with RAPS grade III. Conclusions: In patients with AL amyloidosis, baseline kidney functions are associated with RAPS grade. Renal survival is significantly lower in patients with highest RAPS grade. However, patient survival is not significantly different according to RAPS grade.

  • A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis

    by Aygul Celtik, Sait Sen, Fatma Keklik, Guray Saydam, Gulay Asci, Banu Sarsik, Mehmet Ozkahya, Huseyin Toz

    Purpose Renal involvement is associated with significant morbidity and mortality in AA amyloidosis. Extend of amyloid deposition in kidney biopsies may be predictive for clinical manifestations and outcomes. The aim of our study is to assess clinical features of patients with biopsy-proven renal AA amyloidosis and to evaluate the relationship between histopathological scoring and grading of renal amyloid deposition with clinical findings and outcomes. Methods The study included 86 patients who were diagnosed with renal AA amyloidosis. The demographic and clinical features at the time of biopsy and follow-up data were retrospectively collected. Amyloid deposition in glomeruli, interstitium, vessels and tubulointerstitial findings were scored and renal amyloid prognostic score (RAPS) was assigned by adding all scores. RAPS was further divided into three grades (RAPS grade I, II, III). Results Median age was 50 (36–59) years. Familial Mediterranean fever was the leading cause. RAPS grade and interstitial inflammatory infiltration were associated with baseline eGFR and glomerular amyloid deposition was associated with proteinuria. During the follow-up period (median 50 months), 39 patients developed ESRD. Extensive (involving > 50%) glomerular amyloid deposition, baseline eGFR and proteinuria were independent risk factors for progression to end stage renal disease. Death censored renal survival was significantly lower among patients with RAPS grade III compared to those with RAPS grade I and II. Patient survival rate was not different according to RAPS grade. Conclusions Degree of renal amyloid accumulation is associated with renal function and outcome. The scoring and grading system may be predictive in clinical outcome and contribute to understanding of disease mechanism.


  • Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia

    by Pervin Korkmaz Ekren, Zehra Nur Töreyin, Huriye Berk Takır, Merih Kalamanoğlu Balcı, Ümmügülsüm Gaygısız, Gül Gürsel, Begüm Ergan, Aslıhan Yalçın, Cüneyt Saltürk, Müge Aydoğdu, et al.

    Colistimethate sodium (CMS) is frequently used in the treatment of nosocomial multidrug-resistant gram-negative infections. Nephrotoxicity is the most important side effect. The aim of this study is to evaluate the effect of colistin on nephrotoxicity and to assess prognosis in patients treated with CMS due to hospital-acquired pneumonia (HAP). Patients treated with CMS for HAP due to multidrug-resistant Pseudomonas aeruginosa or Acinetobacter baumannii were included in this cohort study. We evaluated 281 patients treated with two different brands of CMS whose administration dose is different: imported (n= 58, low dose/kg) and domestic (n= 223, high dose/kg). Nephrotoxicity developed in 175 patients (62.3%). The median age (73 vs. 66 years, p= 0.004) and mortality rates were higher (66.9% vs. 52.8%, p= 0.022) in patients having nephrotoxicity. The patients receiving high dose/kg had higher nephrotoxicity rate (67.7% vs. 41.4%, p< 0.001). The clinical, bacteriological response and mortality rates of the whole group were 52.0%, 61.0%, 61.6%, respectively. The clinical and bacteriological response rates were similar in the different dose groups. Multivariate analysis showed that nephrotoxicity was associated with domestic brand depending on use of high dose (OR= 3.97), advanced age (β= 0.29, p= 0.008), male gender (OR= 2.60), hypertension (OR= 2.50), red blood cells transfusion (OR= 2.54), absence of acute kidney injury (OR= 10.19), risk stage of RIFLE (OR= 11.9). Nephrotoxicity is associated with the use of high dose colistin, age, gender, hypertension, red blood cells replacement and RIFLE stage. The mortality rate is higher in patients developing nephrotoxicity.


  • Efficacy and Safety of ATG-Fresenius as an Induction Agent in Living-Donor Kidney Transplantation

    by M. Yilmaz, T.ö. Sezer, E. Günay, I. Solak, A. Çeltik, C. Hoşcoşkun, H. Töz


  • Frequency and Outcomes of Pregnancy on Nocturnal Home Haemodialysis

    by Cenk Demirci, Meltem Seziş Demirci, Gülay Aşçı, Aygül Çeltik, Pınar Seymen, Fatih Kırçelli, Taşkın Çolak, Ercan Ok


  • The effect of hypercalcemia on allograft calcification after kidney transplantation

    by Aygül Çeltik, Sait Şen, Mümtaz Yılmaz, Meltem Seziş Demirci, Gülay Aşçı, Abdülkerim Furkan Tamer, Banu Sarsık, Cüneyt Hoşcoşkun, Hüseyin Töz, Ercan Ok

    Purpose Persistent hypercalcemia after kidney transplantation (KTx) may cause nephrocalcinosis and graft dysfunction. The aim of this study was to evaluate patients with hypercalcemia and assess its effect on tubulointerstitial calcification. Methods A total of 247 recipients were enrolled. Transient and persistent hypercalcemia was defined as hypercalcemia (corrected serum calcium >10.2 mg/dL) persisting for 6 and 12 months after KTx, respectively. The severity of calcification in the 0-h, 6- and 12-month protocol biopsies of patients with transient (n = 8) and persistent hypercalcemia (n = 20) was compared with a matched control group (n = 28). Results Twenty-eight patients were hypercalcemic at 6 months posttransplantation. Serum calcium levels were normalized in eight of them at the end of the first year. Dialysis duration was a positive predictor of persistent hypercalcemia. Tubulointerstitial calcification was detected in 70.6 and 90 % of patients with persistent hypercalcemia at 6 and 12 months posttransplantation, respectively. In 20 % of patients with transient hypercalcemia, severity of calcification regressed at 12 months posttransplantation along with normalization of serum calcium levels. Graft functions and histopathological findings (ci, ct, ci + ct, cv, ah, percentage of sclerotic glomeruli) were not different at 6 and 12 months posttransplantation. Conclusions Hypercalcemia and persistent hyperparathyroidism are not rare after KTx. Tubulointerstitial calcification is more common and progressive among patients with persistent hypercalcemia. Normalization of calcium levels may contribute to regression of calcification in some patients.